| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $12,023,391 ) |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01CA253573 | Targeting aberrant anti-apoptotic signaling for prevention of skin cancer | 000 | 4 | NIH | 4/19/2023 | $326,175 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DK122558 | Skeletal Effects of Type 1 Diabetes | 001 | 4 | NIH | 8/22/2023 | $341,196 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01AG077574 | Regulatory Mechanisms Governing BubR1 Protein Stability During Stress and Aging | 000 | 2 | NIH | 4/12/2023 | $298,275 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R00ES033259 | The Role of Aquaporin 3 in Arsenic-Induced DNA Damage and Mutagenesis | 000 | 3 | NIH | 7/25/2023 | $246,221 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC016680 | Clinical factors in aminoglycoside-induced ototoxicity | 000 | 5 | NIH | 7/26/2023 | $659,676 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01NS126418 | Autoresuscitation and SUDEP | 000 | 2 | NIH | 1/26/2023 | $359,779 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC019918 | Innate Immunity to Spiral Ganglion Neuron Degeneration | 001 | 2 | NIH | 7/13/2023 | -$445,445 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC019918 | Innate Immunity to Spiral Ganglion Neuron Degeneration | 000 | 2 | NIH | 4/27/2023 | $487,118 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | E4C24385 | NSL - Baccalaureate Nursing | 000 | 2 | HRSA | 8/22/2023 | $584,920 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | F32DC020102 | Repurposing FDA-Approved MEK Inhibitor Trametinib for Protection Against Cisplatin-Induced Hearing Loss | 001 | 2 | NIH | 2/7/2023 | $1,990 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | F32DC020102 | Repurposing FDA-Approved MEK Inhibitor Trametinib for Protection Against Cisplatin-Induced Hearing Loss | 000 | 2 | NIH | 1/12/2023 | $69,802 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | P20GM139762 | Translational Hearing Center | 001 | 3 | NIH | 9/11/2023 | $195,724 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21NS132590 | Structure-Function and Signaling of Glutamate Delta 1 in Pain Mechanism | 001 | 1 | NIH | 9/13/2023 | -$404,250 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | P20GM139762 | Translational Hearing Center | 000 | 3 | NIH | 2/9/2023 | $2,116,006 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21NS132590 | Structure-Function and Signaling of Glutamate Delta 1 in Pain Mechanism | 001 | 1 | NIH | 9/13/2023 | $404,250 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | F30DC019528 | Repurposing momelotinib for the prevention of aminoglycoside-induced ototoxicity | 000 | 3 | NIH | 1/13/2023 | $37,979 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21NS132590 | Structure-Function and Signaling of Glutamate Delta 1 in Pain Mechanism | 000 | 1 | NIH | 5/1/2023 | $404,250 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | E1324282 | HPSL - Pharmacy | 000 | 2 | HRSA | 8/22/2023 | $1,000,000 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | F30DC019528 | Repurposing momelotinib for the prevention of aminoglycoside-induced ototoxicity | 001 | 3 | NIH | 2/7/2023 | $942 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | E1119074 | HPSL - Dentistry | 000 | 3 | HRSA | 8/22/2023 | $874,068 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | NU58DP007612 | Center for Promoting Health and Health Equity-Racial and Ethnic Approaches to Community Health 2 (CPHHE-REACH 2) | 00 | 1 | CDC | 8/28/2023 | $302,891 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | NU58DP007612 | Center for Promoting Health and Health Equity-Racial and Ethnic Approaches to Community Health 2 (CPHHE-REACH 2) | 00 | 1 | CDC | 8/28/2023 | $719,008 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01HL164593 | A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma. | 000 | 1 | NIH | 8/29/2023 | $64,908 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC018850 | Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing Loss | 000 | 3 | NIH | 12/20/2022 | $362,571 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01HL164593 | A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma. | 000 | 1 | NIH | 8/29/2023 | $346,204 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC018850 | Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing Loss | 001 | 3 | NIH | 1/18/2023 | $40,286 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R15GM151702 | Examination of Ornithine Decarboxylase Antizyme RNA Structure and Function from Various Organisms for the Development of Antibiological Agents | 000 | 1 | NIH | 7/26/2023 | $440,999 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01NS133050 | Contributions of prion strains and substrains to prion zoonotic potential and evolution | 000 | 1 | NIH | 6/2/2023 | $581,891 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01NS118731 | Trans-synaptic signaling complex in amygdala pain mechanisms | 000 | 4 | NIH | 8/8/2023 | $530,328 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01AI167880 | Redox Regulation of DksA-dependent Borrelia burgdorferi infectivity | 000 | 1 | NIH | 7/26/2023 | $350,000 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01AI167880 | Redox Regulation of DksA-dependent Borrelia burgdorferi infectivity | 000 | 1 | NIH | 7/26/2023 | $74,467 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21DC020773 | Dissecting the sensory hair cell nucleus: Development of a novel method for investigating chromatin interactions (Tn5-Capture) in small cell numbers | 000 | 1 | NIH | 10/21/2022 | $181,875 |
| | 2023 | 2023 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC021070 | Identification and characterization of novel functions for the Usher proteins in the inner ear | 000 | 1 | NIH | 4/27/2023 | $520,111 |
| | 2023 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | D1832118 | Health Careers Opportunity Program | 01 | 5 | HRSA | 4/27/2023 | $0 |
| | 2023 | 2021 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R03HD101115 | Effectiveness of a 6-week hippotherapy program in children with autism spectrum disorder | 000 | 2 | NIH | 9/22/2023 | -$387 |
| | 2023 | 2021 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | E2617683 | PCL - Allopathic Medicine | 001 | 2 | HRSA | 11/28/2022 | $0 |
| | 2023 | 2021 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DK122558 | Skeletal Effects of Type 1 Diabetes | 000 | 3 | NIH | 4/25/2023 | $0 |
| | 2023 | 2020 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R56AI148219 | Roles of reactive oxygen and nitrogen species on vector colonization by tick-borne relapsing fever spirochetes | 000 | 1 | NIH | 9/21/2023 | -$3,214 |
| | 2023 | 2020 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21AI146613 | DCAF1(VprBP) regulates FoxO1 to promote Rag transcription | 000 | 2 | NIH | 7/25/2023 | -$27,508 |
| | 2023 | 2020 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21ES029566 | Neuronal P-Rex1 repression: a key factor in early-life environmental cigarette smoke exposure mediated risk of asthma | 000 | 2 | NIH | 11/24/2022 | $0 |
| | 2023 | 2020 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | K01AG052627 | Mechanisms Controlling BubR1 Regulation of Cancer and Aging | 000 | 5 | NIH | 11/23/2022 | -$19,716 |
| | 2023 | 2020 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC004555 | Hair Cell Responses to Ototoxic Drugs | 000 | 17 | NIH | 5/12/2023 | $0 |
| | 2023 | 2020 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R21NS111389 | Mechanisms of SUDEP: Failure to Autoresuscitate | 000 | 1 | NIH | 9/12/2023 | $0 |
| | 2023 | 2018 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R15GM129701 | Examination of Ornithine Decarboxylase Antizyme RNA Structure and Function for the Development of Antibiological Agents | 001 | 1 | NIH | 12/9/2022 | $0 |
| | 2023 | 2018 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R15GM129701 | Examination of Ornithine Decarboxylase Antizyme RNA Structure and Function for the Development of Antibiological Agents | 000 | 1 | NIH | 11/1/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $12,116,724 ) (Continued on the next page) |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0133 | DOUGLAS | USA | R01DC016807 | Mechanisms of Biological Aging of Cochlear Hair Cells | 000 | 5 | NIH | 7/13/2022 | $376,598 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0002 | DOUGLAS | USA | R21AI153688 | Role of RACK1 in RAG1 degradation and B cell development | 000 | 2 | NIH | 5/19/2022 | $181,875 |
| | 2022 | 2022 | CREIGHTON UNIVERSITY | 2500 CALIFORNIA PLAZA | OMAHA | NE | 68178-0002 | DOUGLAS | USA | R15EY032275 | Novel ocular hypotensive and neuroprotective microparticle-based hydrogen sulfide delivery system | 000 | 1 | NIH | 2/9/2022 | $436,500 |
|
